The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair and The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele

  • Post author:
  • Post category:

UC Davis is conducting a clinical trial for in utero repair of myelomeningocele (MMC), the most severe form of spina bifida.  MMC is a birth defect that occurs due to incomplete…

Continue ReadingThe CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair and The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele

Hearing the Silence: Genome-wide Mapping of Cell-Type-Specific Silencers in the Developing Human Brain

  • Post author:
  • Post category:

Research Objective We will develop genome editing tools to identify silencers that regulate neural stem cell fate, uncovering key DNA elements that guide neurodevelopment and are disrupted in neurodevelopmental diseases…

Continue ReadingHearing the Silence: Genome-wide Mapping of Cell-Type-Specific Silencers in the Developing Human Brain

Modeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment

  • Post author:
  • Post category:

Research Objective Human and animal models of NuRD-deficiency will identify NuRD-subtype function in context of neurogenesis. Multi-omic studies will identify/quantify molecular and cellular changes in NuRD-deficiency. Impact NuRD-deficiency causes several…

Continue ReadingModeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment

Modeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells

  • Post author:
  • Post category:

Research Objective Understanding alveolar progenitor cell defects in T21 and the genes/pathways associated with them will allow for developing therapeutic approaches for individuals with DS. Impact Although trisomy 21 affects…

Continue ReadingModeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells